Stay updated on Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Sign up to get notified when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.

Latest updates to the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page
- Check5 days agoChange DetectedNo meaningful changes were observed in the study record; the page content and eligibility details remain the same.SummaryDifference0.4%

- Check12 days agoNo Change Detected
- Check34 days agoChange DetectedCore content updated with a government funding notice and updated operating-status guidance; version updated from v3.1.0 to v3.2.0.SummaryDifference3%

- Check41 days agoChange DetectedUpdated medical naming to a more specific form and bumped the revision version from v3.0.2 to v3.1.0.SummaryDifference0.5%

- Check55 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.2%

- Check62 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.2%

- Check70 days agoChange DetectedThe web page has been updated to include new resources related to genetic and rare diseases, specifically focusing on various types of cancers and their associated treatments. Additionally, the facility name and location have been added, while some previous location details and specific medical terms have been removed.SummaryDifference5%

Stay in the know with updates to Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Epacadostat & Nivolumab Combo in Immune Therapies Clinical Trial page.